Anna Alkelai

1.8k total citations
30 papers, 625 citations indexed

About

Anna Alkelai is a scholar working on Genetics, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Anna Alkelai has authored 30 papers receiving a total of 625 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Genetics, 8 papers in Molecular Biology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Anna Alkelai's work include Genetics and Neurodevelopmental Disorders (13 papers), Genetic Associations and Epidemiology (11 papers) and Genomics and Rare Diseases (10 papers). Anna Alkelai is often cited by papers focused on Genetics and Neurodevelopmental Disorders (13 papers), Genetic Associations and Epidemiology (11 papers) and Genomics and Rare Diseases (10 papers). Anna Alkelai collaborates with scholars based in United States, Israel and Germany. Anna Alkelai's co-authors include Doron Lancet, Lior Greenbaum, Yoav Kohn, Bernard Lerer, Edna Ben‐Asher, Tsviya Olender, Sara Lupoli, Fabìo Macciardi, Amihai Rigbi and Ming‐Shan Chien and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and PLoS ONE.

In The Last Decade

Anna Alkelai

27 papers receiving 614 citations

Peers

Countries citing papers authored by Anna Alkelai

Since Specialization

Citations

This map shows the geographic impact of Anna Alkelai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Alkelai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Alkelai more than expected).

Fields of papers citing papers by Anna Alkelai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Alkelai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Alkelai. The network helps show where Anna Alkelai may publish in the future.

Co-authorship network of co-authors of Anna Alkelai

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Alkelai. A scholar is included among the top collaborators of Anna Alkelai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Alkelai. Anna Alkelai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Massive Parallel DNA Sequencing of Patients with Inherited Cardiomyopathies in Cyprus and Suggestion of Digenic or Oligogenic Inheritance 2024 ·Genes ·(unknown), Marios Ioannides, Christiana Polydorou, Gregory Papagregoriou, Apostolos Malatras, (unknown), (unknown), (unknown), (unknown), Christos Eftychiou, (unknown), Theodoros Christophides, Anna Alkelai, Manav Kapoor, Alan R. Shuldiner, Panayiotis Avraamides, Constantinos Deltas	0
2	Identification and functional validation of rare coding variants in genes linked to monogenic obesity 2024 ·Obesity ·Çiğdem Köroğlu, Michael Traurig, Yunhua L. Muller, (unknown), Paolo Piaggi, (unknown), (unknown), Robert L. Hanson, Cristopher V. Van Hout, Anna Alkelai, Alan R. Shuldiner, Clifton Bogardus, Leslie J. Baier	1
3	The best of both worlds: Blending cutting‐edge research with clinical processes for a productive exome clinic 2023 ·Clinical Genetics ·Jennifer A. Sullivan, Rebecca C. Spillmann, Kelly Schoch, Sophie Nicole, Anna Alkelai, Nicholas Stong, Patrick R. Shea, Slavé Petrovski, Vaidehi Jobanputra, Allyn McConkie‐Rosell, Vandana Shashi	0
4	Investigation into the genetics of fetal congenital lymphatic anomalies 2023 ·Prenatal Diagnosis ·(unknown), Anna Alkelai, Jessica L. Giordano, (unknown), (unknown), Chia‐Ling Nhan‐Chang, Joshua E. Motelow, Vimla S. Aggarwal, David B. Goldstein, Ronald J. Wapner, Carrie J. Shawber	14
5	Comprehensive Genetic Analysis of Druze Provides Insights into Carrier Screening 2023 ·Genes ·(unknown), Guy Shapira, (unknown), (unknown), Anna Alkelai, Alan R. Shuldiner, Claudia Gonzaga‐Jauregui, Jamal Zidan, (unknown), Noam Shomron, Eitan Friedman	1
6	Genetic insights into childhood-onset schizophrenia: The yield of clinical exome sequencing 2023 ·Schizophrenia Research ·Anna Alkelai, Lior Greenbaum, (unknown), Gundula Povysil, (unknown), Zhong Ren, Joshua E. Motelow, (unknown), (unknown), (unknown), Daniel Hughes, Vaidehi Jobanputra, Sagiv Shifman, David B. Goldstein, Yoav Kohn	8
7	Whole exome sequencing in Alopecia Areata identifies rare variants in KRT82 2022 ·Nature Communications ·(unknown), Sahar Gelfman, (unknown), Eunice Lee, Isha Monga, Anna Alkelai, Iuliana Ionita‐Laza, Lynn Petukhova, Angela M. Christiano	18
8	Alzheimer’s Disease Polygenic Risk Score Is Not Associated With Cognitive Decline Among Older Adults With Type 2 Diabetes 2022 ·Frontiers in Aging Neuroscience ·(unknown), Eric Yu, Ramit Ravona‐Springer, Abigail Livny, (unknown), (unknown), Orit H. Lesman‐Segev, Lang Liu, Ithamar Ganmore, Anna Alkelai, Ziv Gan‐Or, Hung‐Mo Lin, Anthony Heymann, Michal Schnaider Beeri, Lior Greenbaum	1
9	High-impact rare genetic variants in severe schizophrenia 2021 ·Proceedings of the National Academy of Sciences ·Anthony W. Zoghbi, Ryan S. Dhindsa, Terry E. Goldberg, (unknown), Joshua E. Motelow, Xinchen Wang, Anna Alkelai, Matthew Harms, Jeffrey A. Lieberman, Sander Markx, David B. Goldstein	33
10	Association of the CD2AP locus with cognitive functioning among middle-aged individuals with a family history of Alzheimer's disease 2020 ·Neurobiology of Aging ·(unknown), Ramit Ravona‐Springer, Anna Alkelai, Eric Yu, Ziv Gan‐Or, Ithamar Ganmore, Anthony Heymann, Michal Schnaider Beeri, Lior Greenbaum	5
11	Expansion of the GRIA2 phenotypic representation: a novel de novo loss of function mutation in a case with childhood onset schizophrenia 2020 ·Journal of Human Genetics ·Anna Alkelai, (unknown), Lior Greenbaum, (unknown), (unknown), (unknown), Shlomit Rienstein, Neha Dagaonkar, Daniel Hughes, Vimla S. Aggarwal, Erin L. Heinzen, Sagiv Shifman, David B. Goldstein, Yoav Kohn	13
12	TCF7L2 polymorphisms are associated with amygdalar volume in elderly individuals with Type 2 Diabetes 2019 ·Scientific Reports ·Ithamar Ganmore, Abigail Livny, Ramit Ravona‐Springer, Itzik Cooper, Anna Alkelai, Shahar Shelly, Galia Tsarfaty, Anthony Heymann, Michal Schnaider Beeri, Lior Greenbaum	7
13	The human olfactory transcriptome 2016 ·BMC Genomics ·Tsviya Olender, Ifat Keydar, Jayant M. Pinto, (unknown), Anna Alkelai, Ming‐Shan Chien, Simon Fishilevich, Diego Restrepo, Hiroaki Matsunami, Yoav Gilad, Doron Lancet	85
14	Identification of a Functional Risk Variant for Pemphigus Vulgaris in the ST18 Gene 2016 ·PLoS Genetics ·Dan Vodo, Ofer Sarig, Shamir Geller, Edna Ben‐Asher, Tsviya Olender, Ron Bochner, Ilan Goldberg, (unknown), Anna Alkelai, (unknown), A. Peled, Sharon Baum, Aviv Barzilai, Saleh Ibrahim, Detlef Zillikens, Doron Lancet, Eli Sprecher	35
15	Common variants of IRF3 conferring risk of schizophrenia 2015 ·Journal of Psychiatric Research ·Xiao Li, Wen Zhang, Todd Lencz, Ariel Darvasi, Anna Alkelai, Bernard Lerer, Hongyan Jiang, Dengfeng Zhang, Li Yu, Xiufeng Xu, Ming Li, Yong‐Gang Yao	12
16	DOCK4 and CEACAM21 as novel schizophrenia candidate genes in the Jewish population 2011 ·The International Journal of Neuropsychopharmacology ·Anna Alkelai, Sara Lupoli, Lior Greenbaum, Yoav Kohn, (unknown), Edna Ben‐Asher, Doron Lancet, Fabìo Macciardi, Bernard Lerer	41
17	Support for association of HSPG2 with tardive dyskinesia in Caucasian populations 2011 ·The Pharmacogenomics Journal ·Lior Greenbaum, Anna Alkelai, (unknown), Yoav Kohn, Bernard Lerer	27
18	Evidence for association of the GLI2 gene with tardive dyskinesia in patients with chronic schizophrenia 2010 ·Movement Disorders ·Lior Greenbaum, Anna Alkelai, Amihai Rigbi, Yoav Kohn, Bernard Lerer	36
19	Why do young women smoke? VII COMT as a risk modifying gene for Nicotine dependence – role of gene–gene interaction, personality, and environmental factors 2010 ·Human Psychopharmacology Clinical and Experimental ·Lior Greenbaum, Kyra Kanyas, Amihai Rigbi, Anna Alkelai, Yoav Kohn, Bernard Lerer	5
20	Evidence for an interaction of schizophrenia susceptibility loci on chromosome 6q23.3 and 10q24.33–q26.13 in Arab Israeli families 2009 ·American Journal of Medical Genetics Part B Neuropsychiatric Genetics ·Anna Alkelai, Yoav Kohn, (unknown), (unknown), Amihai Rigbi, (unknown), Edna Ben‐Asher, Doron Lancet, Bernard Lerer	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact